{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=fluticasone+furoate+%28FF%29", "query": { "intervention": "fluticasone furoate (FF)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 47, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=fluticasone+furoate+%28FF%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T15:24:56.747Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00398476", "title": "Fluticasone Nasal Spray Patient Preference Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "fluticasone propionate (FP)", "type": "DRUG" }, { "name": "fluticasone furoate (FF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 127, "start_date": "2006-12-01", "completion_date": "2006-12-04", "has_results": true, "last_update_posted_date": "2018-03-01", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 14, "location_summary": "Fountain Valley, California • Long Beach, California • San Diego, California + 11 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00398476" }, { "nct_id": "NCT07282886", "title": "VENTURI (VENTilation Using Respiratory Imaging)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI", "type": "DRUG" }, { "name": "Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2026-03-15", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282886" }, { "nct_id": "NCT03478696", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 732, "start_date": "2018-06-25", "completion_date": "2019-03-18", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 42, "location_summary": "Mobile, Alabama • Bakersfield, California • Sacramento, California + 35 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478696" }, { "nct_id": "NCT02730351", "title": "Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate/ Vilanterol 100 mcg/25 mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg", "type": "DRUG" }, { "name": "Placebo via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Placebo via DISKUS / ACCUHALER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 75, "start_date": "2016-05-25", "completion_date": "2017-02-03", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 13, "location_summary": "Huntington Beach, California • Los Angeles, California • San Diego, California + 9 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02730351" }, { "nct_id": "NCT01563029", "title": "A Dose-ranging Study of Fluticasone Furoate (FF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 597, "start_date": "2012-03-28", "completion_date": "2014-09-24", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 37, "location_summary": "Little Rock, Arkansas • Costa Mesa, California • Huntington Beach, California + 33 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01563029" }, { "nct_id": "NCT01453023", "title": "Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Fluticasone Furoate/Vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 26, "start_date": "2011-10", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 1, "location_summary": "Huntington Beach, California", "locations": [ { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01453023" }, { "nct_id": "NCT01894386", "title": "Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF 400 mcg", "type": "DRUG" }, { "name": "UMEC 500 mcg", "type": "DRUG" }, { "name": "UMEC 250 mcg", "type": "DRUG" }, { "name": "VI 100 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2013-07-15", "completion_date": "2013-09-26", "has_results": false, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01894386" }, { "nct_id": "NCT00403286", "title": "A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Fluticasone Propionate/Formoterol Fumarate", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Xinafoate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 457, "start_date": "2006-11", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2009-06-30", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 49, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Phoenix, Arizona + 44 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Buena Park", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00403286" }, { "nct_id": "NCT03474081", "title": "A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA inhaler", "type": "DEVICE" }, { "name": "HANDIHALER", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 800, "start_date": "2018-03-29", "completion_date": "2019-07-17", "has_results": true, "last_update_posted_date": "2021-07-15", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 33, "location_summary": "Andalusia, Alabama • Huntington Beach, California • Sacramento, California + 29 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Simi Valley", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03474081" }, { "nct_id": "NCT02573870", "title": "Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Batefenterol + Fluticasone Furoate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 63, "start_date": "2015-12-01", "completion_date": "2016-07-05", "has_results": true, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-09-28T15:24:56.747Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Hollywood, Florida • Baltimore, Maryland + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Gastonia", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573870" } ] }